Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
nearly eliminating the hCD45+ MV-4-11 cells at the 75 mg/kg dose in the blood (mean
InChiKey: BBAOKSZCULLDIW-UHFFFAOYSA-N
LG100754 is an insulin sensitizer that functions through RXR
3-CETC is a fluorescent CYP1A1 &1A2 substrate
hVEGF-IN-1 ol-7-O-β-D-glucopyranoside nearly eliminating the hCD45+ MV-4-11hVEGF IN 1, a quinazoline derivative, could specifically bind to the G rich sequence in the internal ribosome entry site A (IRES A) and destabilize the G quadruplex structure. hVEGF IN 1 binds to the IRES A (WT) with a Kd of 0. 928 M in SPR experiments. hVEGF IN 1 could hinder tumor cells migration and repress tumor growth by decreasing VEGF A protein expression. Product information CAS Number: 1637443 98 1 Molecular Weight: 581. 75 Formula:
US$ 29.95
US$ 249.97
US$ 59.95
US$ 1249.97
US$ 29.95
US$ 35.57
US$ 219.97